1Mukherjee D, Patil CG (2012) Epidemiology and the global burden of stroke. World Neurosurg 76: S85-90.

2Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, et al. (2010) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study. Lancet 380: 2095-2128.

3Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, et al. (2010) Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2197-2223.

4Knecht S, Hesse S, Oster P (2011) Rehabilitation after stroke. Dtsch Arztebl Int 108: 600-606.

5Hankey GJ (2003) Long-term outcome after ischaemic stroke/transient ischaemic attack. Cerebrovasc Dis 1:14-19.

6Pearson-Fuhrhop KM, Kleim JA, Cramer SC (2009) Brain plasticity and genetic factors. Top Stroke Rehabil 16: 282-299.

7Czlonkowska A, Kurkowska-Jastrzebska I (2010) Inflammation and gliosis in neurological diseases--clinical implications. J Neuroimmunol 231: 78-85.

8Becker KJ (2010) Modulation of the postischemic immune response to improve stroke outcome. Stroke 41: S75-78.

9Yamada Y, Ichihara S, Nishida T (2008) Proinflammatory gene polymorphisms and ischemic stroke. Curr Pharm Des 14: 3590-3600.

10Ait-Oufella H, Taleb S, Mallat Z, Tedgui A (2011) Recent advances on the role of cytokines in atherosclerosis. Arterioscler Thromb Vasc Biol 31: 969-979.

11Matsumoto T, Ikeda K, Mukaida N, Harada A, Matsumoto Y, et al. (1997) Prevention of cerebral edema and infarct in cerebral reperfusion injury by an antibody to interleukin-8. Lab Invest 77: 119-125.

12Garau A, Bertini R, Colotta F, Casilli F, Bigini P, et al. (2005) Neuroprotection with the CXCL8 inhibitor repertaxin in transient brain ischemia. Cytokine 30: 125-131.

13Villa P, Triulzi S, Cavalieri B, Di Bitondo R, Bertini R, et al. (2007) The interleukin-8 (IL-8/CXCL8) receptor inhibitor reparixin improves neurological deficits and reduces long-term inflammation in permanent and transient cerebral ischemia in rats. Mol Med 13: 125-133.

14Kostulas N, Pelidou SH, Kivisakk P, Kostulas V, Link H (1999) Increased IL-1beta, IL-8, and IL-17 mRNA expression in blood mononuclear cells observed in a prospective ischemic stroke study. Stroke 30: 2174-2179.

15Tarkowski E, Rosengren L, Blomstrand C, Wikkelso C, Jensen C, et al. (1997) Intrathecal release of pro- and anti-inflammatory cytokines during stroke. Clin Exp Immunol 110: 492-499.

16Domac FM, Misirli H (2008) The role of neutrophils and interleukin-8 in acute ischemic stroke. Neurosciences (Riyadh) 13:136-141.

17Grau AJ, Reis A, Buggle F, Al-Khalaf A, Werle E, et al. (2001) Monocyte function and plasma levels of interleukin-8 in acute ischemic stroke. J Neurol Sci 192: 41-47.

18Kostulas N, Kivisakk P, Huang Y, Matusevicius D, Kostulas V, et al. (1998) Ischemic stroke is associated with a systemic increase of blood mononuclear cells expressing interleukin-8 mRNA. Stroke 29: 462-466.

19Grau AJ, Aulmann M, Lichy C, Meiser H, Buggle F, et al. (2001) Increased cytokine release by leucocytes in survivors of stroke at young age. Eur J Clin Invest 31: 999-1006.

20Kis Z, Sas K, Gyulai Z, Treso B, Petrovay F, et al. (2007) Chronic infections and genetic factors in the development of ischemic stroke. New Microbiol 30: 213-220.

21Enquobahrie DA, Smith NL, Bis JC, Carty CL, Rice KM, et al. (2008) Cholesterol ester transfer protein, interleukin-8, peroxisome proliferator activator receptor alpha, and Toll-like receptor 4 genetic variations and risk of incident nonfatal myocardial infarction and ischemic stroke. Am J Cardiol 101: 1683-1688.

22Colobran R, Pujol-Borrell R, Armengol MP, Juan M (2007) The chemokine network. II. On how polymorphisms and alternative splicing increase the number of molecular species and configure intricate patterns of disease susceptibility. Clin Exp Immunol 150: 1-12.

23Heinzmann A, Ahlert I, Kurz T, Berner R, Deichmann KA (2004) Association study suggests opposite effects of polymorphisms within IL8 on bronchial asthma and respiratory syncytial virus bronchiolitis. J Allergy Clin Immunol 114: 671-676.

24Li Z, Luo S, Wang F, Zhen J, Sun H, et al. (20102) An association study between polymorphisms of the Fractalkine receptor gene, CX3CR1, and cerebral infarction in the Han Chinese population. J Neurol Sci 320: 12-15.

25Tunstall-Pedoe H (2003) MONICA monograph and multimedia sourcebook: world's largest study of heart disease, stroke, risk factors, and population trends 1979-2002. World Health Organization Publishers.

26Lyden P, Brott T, Tilley B, Welch KM, Mascha EJ, et al. (1994) Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group. Stroke 25: 2220-2226.

27Shah S, Vanclay F, Cooper B (1989) Improving the sensitivity of the Barthel Index for stroke rehabilitation. J Clin Epidemiol 42: 703-709.

28Luo S, Wang F, Li Z, Deng J (2013) Effect of the +781C/T Polymorphism in the Interleukin-8 Gene on Atherosclerotic Cerebral Infarction, and Its Interaction with Smoking and Drinking. PloS one 8:e80246.

29Giannakopoulou E, Ragia G, Marousi S, Ellul J, Manolopoulos VG, et al. (2013) Association of monocyte chemoattractant protein-1 -2518A>G polymorphism with occurrence, severity, and outcome in ischemic stroke. Neurol Sci 34: 1315-1320.

30Ferrarese C, Mascarucci P, Zoia C, Cavarretta R, Frigo M, et al. (1999) Increased cytokine release from peripheral blood cells after acute stroke. J Cereb Blood Flow Metab 19: 1004-1009.

31Manolescu BN, Berteanu M, Dumitru L, Dinu H, Iliescu A, et al. (2010) Dynamics of inflammatory markers in post-acute stroke patients undergoing rehabilitation. Inflammation 34: 551-558.

32Al-Bahrani A, Taha S, Shaath H, Bakhiet M (2007) TNF-alpha and IL-8 in acute stroke and the modulation of these cytokines by antiplatelet agents. Curr Neurovasc Res 4: 31-37.

33Yang YY, Hu CJ, Chang SM, Tai TY, Leu SJ (2004) Aspirin inhibits monocyte chemoattractant protein-1 and interleukin-8 expression in TNF-alpha stimulated human umbilical vein endothelial cells. Atherosclerosis 174: 207-213.

34Hoffmann E, Dittrich-Breiholz O, Holtmann H, Kracht M (2002) Multiple control of interleukin-8 gene expression. J Leukoc Biol 72: 847-855.